TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER

削减癌症项目旨在加强和提高斯洛文尼亚国家生物研究所（NIB）的研究和创新能力和卓越水平。这将通过与三所国际知名机构开展有针对性的结对活动来实现；来自英国的斯旺西大学，瑞典的斯德哥尔摩大学和荷兰的阿姆斯特丹自由医学中心，所有这些都提供了NIB高度期望和需要的具体，独特和互补的知识和专业知识。随着基础设施的不断改进和重要的研究设备升级，CutCancer将能够实施尖端的方法和方法（包括先进的体外3D细胞模型，空间和单细胞分析），促进临床前3D癌症研究领域的前沿研究。CutCancer将包括发展研究机构之间的协同作用，促进网络和参与未来的研究和创新过程。CutCancer的目标是超越纯粹的科学方面，提高NIB的管理和行政能力，达到顶级水平。结对活动将包括具体的实践培训、专家访问、网络研讨会、研讨会和暑期学校、工作见习和最佳实践交流，针对战略选择的研究和行政领域。研究结果将在国际和区域会议以及针对从科学界到卫生部门、专业网络、学生和公众等相关利益攸关方的有针对性的活动上传播。CutCancer的战略行动计划将确保该项目在联盟内外带来长期合作。这将包括NIB协调的未来研究项目，以及共享基础设施和新实施的方法、方法和战略所带来的创新，这些都是CutCancer项目期间的目标。

The CutCancer project aims to strengthen and increase the research and innovation capacity and excellence of the National institute of Biology (NIB) in Slovenia. This will be achieved through targeted twinning activities with three internationally renowned institutions; Swansea University from the UK, Stockholm University from Sweden and VU Medical Centre Amsterdam from the Netherlands, all of which poses specific, unique and complementary knowledge and expertise that is highly desired and needed at NIB. Together with ongoing substantial infrastructural improvements and significant research equipment upgrades, CutCancer will enable implementation of cutting-edge approaches and methodologies (including advanced in vitro 3D cell models, spatial and single-cell analyses), facilitating frontier research in the field of preclinical 3D cancer research. CutCancer will encompass the development of synergies between research institutions, fostering networking and participation in future Research and Innovation processes. CutCancer aims to go beyond the purely scientific aspects and raise the management and administrative capacity of NIB to reach top level. Twinning activities will include specific hands-on training, expert visits, webinars, workshops and summer schools, job shadowing and exchange of best practices, targeting strategically selected research and administrative areas. Results will be disseminated at international and regional conferences and targeted events for relevant stakeholders ranging from the scientific community to the health sector, professional networks, students and general public. The CutCancer´s strategic action plan will ensure that the project leads to long-term collaborations within the consortium and beyond. This will include future research projects coordinated by NIB, as well as the sharing of infrastructure and innovations brought by the newly implemented methods, approaches and strategies, targeted during the CutCancer project.